Adiponectin and breast cancer risk

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 3, 2004, Pages 1102-1107

  Mantzoros, Christos ^a   Petridou, Eleni ^b,c   Dessypris, Nick ^b   Chavelas, Charilaos ^b   Dalamaga, Maria ^b   Alexe, Delia Marina ^b   Papadiamantis, Yannis ^d   Markopoulos, Christos ^b   Spanos, Evangelos ^e   Chrousos, George ^b,f   Trichopoulos, Dimitrios ^b,c  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d HELENA VENIZELOU HOSPITAL   (Greece)

^e International Diagnostic Centre   (Greece)

^f EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; LEPTIN; SOMATOMEDIN;

ADULT; AGED; ARTICLE; BODY MASS; BREAST CANCER; CANCER RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; PREMENOPAUSE; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL SIGNIFICANCE;

ADIPONECTIN; ADULT; AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; HUMANS; INCIDENCE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LOGISTIC MODELS; MIDDLE AGED; POSTMENOPAUSE; PREMENOPAUSE; PROTEINS; RISK FACTORS;

EID: 12144285739     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-031804     Document Type: Article

References (41)

1. Lippman ME 1998 Endocrine responsive cancers. In: Wilson JD, Foster DW, Kronenberg HM, Larsen PR, eds. Williams textbook of endocrinology, 9th Ed. Philadelphia: Saunders; 1675-1692
2. Stoll BA 2002 Upper abdominal obesity, insulin resistance and breast cancer risk. Int J Obes Relat Metab Disord 26:747-753
3. Mantzoros CS, Flier JS 1995 Insulin resistance: the clinical spectrum. Adv Endocrinol Metab 6:193-232
4. Dananberg J, Caro JF 2001 Obesity. In: DeGroot L, ed. Endocrinology, 4th Ed. Philadelphia: Saunders; vol 1:615-630
5. Bruning PF, Bonfrer JM, van Noord PA, Hart AA, deJong-Bakker M, Nooijen WJ 1992 Insulin resistance and breast-cancer risk. Int J Cancer 52:511-516
6. Bruning PF, van Doorn J, Bonfrer JMG, Van Noord PA, Korse CM, Linders TC, Hart AA 1995 Insulin-like growth-factor-binding protein 3 is decreased in early-stage operable pre-menopausal breast cancer. Int J Cancer 62:266-270
7. Del Giudice ME, Fantus IG, Ezzat S, McKeown-Eyssen G, Page D, Goodwin PJ 1998 Insulin and related factors in premenopausal breast cancer risk. Breast Cancer Res Treat 47:111-120
8. Bohlke K, Cramer D, Trichopoulos D, Mantzoros C 1998 Insulin like growth factor 1 in relation to premenopausal ductal carcinoma in situ of the breast: a case-control study. Epidemiology 9:570-573
9. Hankinson S, Willett W, Colditz GA, Hunter DJ, Michaud DS, Deroo B, Rosner B, Speizer FE, Pollak M 1998 Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 351:1393-1396
10. Moschos SJ, Mantzoros CS 2002 The role of the IGF system in cancer: from basic to clinical studies and clinical applications. Oncology 63:317-332
11. Nakano Y, Tobe T, Choi-Miura NH, Mazda T, Tomita M 1996 Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. J Biochem 120:803-812
12. Hu E, Liang P, Spiegelman BM 1996 Adipol is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 271:10697-10703
13. Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara K 1996 cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (adipose most abundant gene transcript 1). Biochem Biophys Res Commun 221:286-289
14. Stefan N, Vozarova B, Funahashi T, Matsuzawa Y, Weyer C, Lindsay RS, Youngren JF, Havel PJ, Pratley RE, Bogardus C, Tataranni PA 2002 Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. Diabetes 51:1884-1888
15. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y 1999 Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257:79-83
16. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA 2001 Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86:1930-1935
17. Petridou E, Mantzoros C, Dessypris N, Koukoulomatis P, Addy C, Voulgaris Z, Chrousos G, Trichopoulos D 2003 Plasma adiponectin concentrations in relation to endometrial cancer: a case control study in Greece. J Clin Endocrinol Metab 88:993-997
18. Michels KB, Solomon CG, Hu FB, Rosner BA, Hankinson SE, Colditz GA, Manson JE 2003 Type 2 diabetes and subsequent incidence of breast cancer in the Nurses' Health Study. Diabetes Care 26:1752-1758
19. Stoll BA 1999 Western Nutrition and the insulin resistance syndrome: a link to breast cancer. Eur J Clin Nutr 53:83-87
20. Petridou E, Koukoulomatis P, Alexe D, Voulgaris Z, Spanos E, Trichopoulos D 2003 Endometrial cancer and the IGF system: a case control study in Greece. Oncology 64:341-345
21. Petridou E, Belechri M, Dessypris N, Koukoulomatis P, Diakomanolis E, Spanos E, Trichopoulos D 2002 Leptin and Body Mass Index in relation to endometrial cancer risk. Ann Nutr Metab 46:147-151
22. Cleary MP, Maihle NJ 1997 The role of body mass index in the relative risk of developing premenopausal versus postmenopausal breast cancer. Proc Soc Exp Biol Med 216:28-43
23. Franceschi S, Favero A, La Vecchia C, Baron AE, Negri E, Dal Maso L, Giacosa A, Montella M, Conti E, Amadori D 1996 Body size indices and breast cancer risk before and after menopause. Int J Cancer 67:181-186
24. van den Brandt PA, Spiegelman D, Yaun SS, Adami HO, Beeson L, Folsom AR, Fraser G, Goldbohm RA, Graham S, Kushi L, Marshall JR, Miller AB, Rohan T, Smith-Warner SA, Speizer FE, Willett WC, Wolk A, Hunter DJ 2000 Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol 152:514-527
25. Yamamoto Y, Hirose H, Saito I, Tomita M, Taniyama M, Matsubara K, Okazaki Y, Ishii T, Nishikai K, Saruta T 2002 Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population. Clin Sci (Lond) 103:137-142
26. Stefan N, Bunt JC, Salbe AD, Funahashi T, Matsuzawa Y, Tataranni PA 2002 Plasma adiponectin concentrations in children: relationships with obesity and insulinemia. J Clin Endocrinol Metab 87:4652-4656
27. Weiderpass E, Gridley G, Persson I, Nyrén O, Ekbom A, Adami HO 1997 Risk of endometrial and breast cancer in patients with diabetes mellitus. Int J Cancer 71:360-363
28. Goodwin PJ, Ennis M, Pritchard KI, Trudeau ME, Koo J, Madarnas Y, Hartwick W, Hoffman B, Hood N 2002 Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. J Clin Oncol 20:42-51
29. Jernstrom H, Barrett-Connor E 1999 Obesity, weight change, fasting insulin, proinsulin, C-peptide, and insulin-like growth factor-1 levels in women with and without breast cancer; the Rancho Bernardo Study. J Womens Health Gend Based Med 8:1265-1272
30. Mink PJ, Shahar E, Rosamond WD, Alberg AJ, Folsom AR 2002 Serum insulin and glucose levels and breast cancer incidence: the atherosclerosis risk in communities study. Am J Epidemiol 156:349-352
31. Milazzo G, Giorgino F, Damante G, Sung C, Stampfer MR, Vigneri R, Goldfine ID, Belfiore A 1992 Insulin receptor expression and function in human breast cancer cell lines. Cancer Res 52:3924-3930
32. Lai A, Sarcevic B, Prall OW, Sutherland RL 2001 Insulin/insulin-like growth factor-I and estrogen cooperate to stimulate cyclin E-Cdk2 activation and cell cycle progression in MCF-7 breast cancer cells through differential regulation of cyclin E and p21(WAF1/Cip1). J Biol Chem 276:25823-25833
33. Kaleko M, Rutter WJ, Miller AD 1990 Overexpression of the human insulinlike growth factor I receptor promotes ligand-dependent neoplastic transformation. Mol Cell Biol 10:464-473
34. van der Burg B, Rutteman GR, Blankenstein MA, de Laat SW, van Zoelen EJ 1988 Mitogenic stimulation of human breast cancer cells in a growth factor-defined medium: synergistic action of insulin and estrogen. J Cell Physiol 134:101-108
35. Bachelder RE, Wendt MA, Mercurio AM 2002 Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4. Cancer Res 62:7203-7206
36. Mick GJ, Wang X, McCormick K 2002 White adipocyte vascular endothelial growth factor: regulation by insulin. Endocrinology 143:948-953
37. Mueller E, Sarraf P, Tontonoz P, Evans RM, Martin KJ, Zhang M, Fletcher C, Singer S, Spiegelman BM 1998 Terminal differentiation of human breast cancer through PPARγ. Mol Cell 1:465-470
38. Yamauchi T, Kamon J, Waki H, Murakami K, Motojima K, Komeda K, Ide T, Kubota N, Terauchi Y, Tobe K, Miki H, Tsuchida A, Akanuma Y, Nagai R, Kimura S, Kadowaki T 2001 The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPARγa) deficiency and PPARγ agonist improve insulin resistance. J Biol Chem 276:41245-41254
39. Ouchi N, Kihara S, Arita Y, Okamoto Y, Maeda K, Kuriyama H, Hotta K, Nishida M, Takahashi M, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Funahashi T, Matsuzawa Y 2000 Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-κB signaling through a cAMP-dependent pathway. Circulation 102:1296-1301
40. Shibata A, Nagaya T, Imai T, Funahashi H, Nakao A, Seo H 2002 Inhibition of NF-κB activity decreases the VEGF mRNA expression in MDA-MB-231 breast cancer cells. Breast Cancer Res Treat 73:237-243
41. Gavrila A, Chan JL, Yiannakouris N, Kontogianni M, Miller LC, Orlova C, Mantzoros CS 2003 Serum adiponectin levels are inversely associated with overall and central fat distribution but are not directly regulated by acute fasting or leptin administration in humans: cross-sectional and interventional studies. J Clin Endocrinol Metab 88:4823-4831